CNBC host Jim Cramer said on Monday that “only a hack” would want to succeed Federal Reserve Chair Jerome Powell after the Justice Department opened a criminal investigation into his handling of a ...

Democratic Sen. Elizabeth Warren of Massachusetts said that President Donald Trump called her on Monday following a speech in which she sharply criticized his record on costs and governance. "This ...

'Mad Money' host Jim Cramer discusses the DOJ targeting Fed Chair Powell and how it impacts markets and Pres. Trump's attempt to cap credit card interest.

'Mad Money' host Jim Cramer discusses the DOJ targeting Fed Chair Powell and how it impacts markets.

Democratic Sen. Elizabeth Warren called on her party Monday to “read the room” and begin appealing to a wider swath of the working-class public by keeping a stringent focus on the economy. “Americans ...

CNBC host Jim Cramer warned investors on Monday that chasing oil stocks amid the Venezuela turmoil is a “suboptimal” strategy, urging them instead to pivot toward undervalued sectors like banking for ...

TV host and market veteran Jim Cramer has made a career out of helping everyday investors navigate Wall Street. The Mad Money host says there’s one investing strategy that can destroy your chances of ...

Amazon rose only 5% in the past year and trades at 32 times trailing P/E. AWS needs to re-accelerate growth as AI adoption increases to drive meaningful upside. Evercore ISI set a $335 price target ...

Peter Gratton, Ph.D., is a New Orleans-based editor and professor with over 20 years of experience in investing, risk management, and public policy. Peter began covering markets at Multex (Reuters) ...

Monday - Friday, 6:00 - 7:00 PM ET CNBC's Jim Cramer gave advice on how to build a balanced portfolio, suggesting investors both individual growth stocks and index funds. "Putting some money in an ...

Enbridge plans to add $8B in new projects next year to boost cash flow and dividend capacity. Pfizer generated $14B in free cash flow this year. Its Seagen and Metsera acquisitions target oncology and ...